Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGENERATE-DCM: G-CSF and Bone Marrow Cells in Dilated Cardiomyopathy
NCT01302171Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Aug 2010
- Primary completion
- Dec 2012
- Modality
- Cytokines & Interferons, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of lenograstim, bone marrow mononuclear cells in dilated cardiomyopathy (DCM), sponsored by Barts Health NHS Trust. Started Aug 2010; status: completed.
02
Drugs
lenograstimbone marrow mononuclear cells
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01302171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302171.